{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T15:58:35Z","timestamp":1779119915812,"version":"3.51.4"},"reference-count":30,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"GlaxoSmithKline Biologicals"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1016\/j.vaccine.2010.12.125","type":"journal-article","created":{"date-parts":[[2011,1,15]],"date-time":"2011-01-15T04:17:08Z","timestamp":1295065028000},"page":"2120-2126","source":"Crossref","is-referenced-by-count":21,"title":["Pandemic H1N1 vaccine requires the use of an adjuvant to protect against challenge in na\u00efve ferrets"],"prefix":"10.1016","volume":"29","author":[{"given":"Beno\u00eet","family":"Baras","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leon","family":"de Waal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koert J.","family":"Stittelaar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Val\u00e9rie","family":"Jacob","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Giannini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edwin J.B.","family":"Veldhuis Kroeze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judith M.A.","family":"van den Brand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geert","family":"van Amerongen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James H.","family":"Simon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanuel","family":"Hanon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sally P.","family":"Mossman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert D.M.E.","family":"Osterhaus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5934","key":"10.1016\/j.vaccine.2010.12.125_bib0005","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1126\/science.1176062","article-title":"Pandemic potential of a strain of influenza A (H1N1): early findings","volume":"324","author":"Fraser","year":"2009","journal-title":"Science"},{"issue":"20","key":"10.1016\/j.vaccine.2010.12.125_bib0010","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1056\/NEJMoa0906453","article-title":"Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus","volume":"361","author":"Hancock","year":"2009","journal-title":"N Engl J Med"},{"issue":"9523","key":"10.1016\/j.vaccine.2010.12.125_bib0015","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1016\/S0140-6736(06)68656-X","article-title":"Safety and immunogenicity of an inactivated split-virion influenza A\/Vietnam\/1194\/2004 (H5N1) vaccine: phase I randomised trial","volume":"367","author":"Bresson","year":"2006","journal-title":"Lancet"},{"issue":"9587","key":"10.1016\/j.vaccine.2010.12.125_bib0020","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/S0140-6736(07)61297-5","article-title":"Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: a randomised controlled trial","volume":"370","author":"Leroux-Roels","year":"2007","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.vaccine.2010.12.125_bib0025","doi-asserted-by":"crossref","first-page":"e1665","DOI":"10.1371\/journal.pone.0001665","article-title":"Broad Clade 2 cross-reactive immunity induced by an adjuvanted clade 1 rH5N1 pandemic influenza vaccine","volume":"3","author":"Leroux-Roels","year":"2008","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.vaccine.2010.12.125_bib0030","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1016\/j.vaccine.2009.12.014","article-title":"Immunogenicity and safety in adults of one dose of influenza A H1N1v 2009 vaccine formulated with and without AS03A-adjuvant: preliminary report of an observer-blind, randomised trial","volume":"28","author":"Roman","year":"2010","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2010.12.125_bib0035","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1086\/505229","article-title":"Ferrets and the challenges of H5N1 vaccine formulation","volume":"194","author":"Hampson","year":"2006","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2010.12.125_bib0040","doi-asserted-by":"crossref","first-page":"e1401","DOI":"10.1371\/journal.pone.0001401","article-title":"Cross-protection against lethal H5N1 challenge in ferrets with an adjuvanted pandemic influenza vaccine","volume":"3","author":"Baras","year":"2008","journal-title":"PLoS One"},{"issue":"5939","key":"10.1016\/j.vaccine.2010.12.125_bib0045","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1126\/science.1177127","article-title":"Pathogenesis and transmission of swine-origin 2009 A(H1N1) influenza virus in ferrets","volume":"325","author":"Munster","year":"2009","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.vaccine.2010.12.125_bib0050","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1086\/651132","article-title":"Severity of pneumonia due to new H1N1 influenza virus in ferrets is intermediate between that due to seasonal H1N1 virus and highly pathogenic avian influenza H5N1 virus","volume":"201","author":"van den Brand","year":"2010","journal-title":"J Infect Dis"},{"issue":"12","key":"10.1016\/j.vaccine.2010.12.125_bib0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1126\/scitranslmed.3000564","article-title":"Seasonal influenza vaccine provides priming for A\/H1N1 immunization","volume":"1","author":"Del Giudice","year":"2009","journal-title":"Sci Trans Med"},{"issue":"9708","key":"10.1016\/j.vaccine.2010.12.125_bib0060","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0140-6736(09)62026-2","article-title":"Immune response after a single vaccination against 2009 influenza A H1N1 in USA: a preliminary report of two randomised controlled phase 2 trials","volume":"375","author":"Plennevaux","year":"2010","journal-title":"Lancet"},{"issue":"36","key":"10.1016\/j.vaccine.2010.12.125_bib0065","doi-asserted-by":"crossref","first-page":"4983","DOI":"10.1016\/j.vaccine.2009.05.079","article-title":"Infection of mice with a human influenza A\/H3N2 virus induces protective immunity against lethal infection with influenza A\/H5N1 virus","volume":"27","author":"Kreijtz","year":"2009","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2010.12.125_bib0070","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1007\/BF01863914","article-title":"Beitrag zur kollektiven Behandlung pharmakologischer Reihenversuche","volume":"162","author":"K\u00e4rber","year":"1931","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"issue":"48","key":"10.1016\/j.vaccine.2010.12.125_bib0075","doi-asserted-by":"crossref","first-page":"20365","DOI":"10.1073\/pnas.0911580106","article-title":"Pre-existing immunity against swine-origin H1N1 influenza viruses in the general human population","volume":"106","author":"Greenbaum","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2010.12.125_bib0080","article-title":"Molecular modeling of swine influenza A\/H1N1, Spanish H1N1, and avian H5N1 flu N1 neuraminidases bound to Tamiflu and Relenza","author":"Le","year":"2009","journal-title":"PLoS Curr Influenza"},{"issue":"10","key":"10.1016\/j.vaccine.2010.12.125_bib0085","doi-asserted-by":"crossref","first-page":"6333","DOI":"10.4049\/jimmunol.176.10.6333","article-title":"T cell responses are better correlates of vaccine protection in the elderly","volume":"176","author":"McElhaney","year":"2006","journal-title":"J Immunol"},{"issue":"9\u201310","key":"10.1016\/j.vaccine.2010.12.125_bib0090","first-page":"1180","article-title":"A randomized, double blind study in young healthy adults comparing cell mediated and humoral immune responses induced by influenza ISCOM\u2122 vaccines and conventional vaccines","volume":"19","author":"Rimmelzwaan","year":"2001","journal-title":"Vaccine"},{"issue":"4 Suppl.","key":"10.1016\/j.vaccine.2010.12.125_bib0095","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1038\/nm1210","article-title":"Targeting the innate immune response with improved vaccine adjuvants","volume":"11","author":"Pashine","year":"2005","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.vaccine.2010.12.125_bib0100","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.1365-2249.2004.02371.x","article-title":"Cellular immunity induced by the recombinant Plasmodium falciparum malaria vaccine, RTS, S\/AS02, in semi-immune adults in The Gambia","volume":"135","author":"Pinder","year":"2004","journal-title":"Clin Exp Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2010.12.125_bib0105","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/nm1009","article-title":"A CD4+ T-cell immune response to a conserved epitope in the circumsporozoite protein correlates with protection from natural Plasmodium falciparum infection and disease","volume":"10","author":"Reece","year":"2004","journal-title":"Nat Med"},{"issue":"20","key":"10.1016\/j.vaccine.2010.12.125_bib0110","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1016\/j.vaccine.2004.11.034","article-title":"Potent enhancement of cellular and humoral immune responses against recombinant hepatitis B antigens using AS02A adjuvant in healthy adults","volume":"23","author":"Vandepapeli\u00e8re","year":"2005","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2010.12.125_bib0115","doi-asserted-by":"crossref","first-page":"3312","DOI":"10.1128\/JVI.02226-09","article-title":"Assessment of seasonal influenza A specific CD4 T cell responses to 2009 pandemic H1N1 swine-origin influenza A virus","volume":"84","author":"Ge","year":"2010","journal-title":"J Virol"},{"issue":"4","key":"10.1016\/j.vaccine.2010.12.125_bib0120","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1586\/erv.09.15","article-title":"Current status and progress of prepandemic and pandemic influenza vaccine development","volume":"8","author":"Leroux-Roels","year":"2009","journal-title":"Expert Rev Vaccines"},{"issue":"25","key":"10.1016\/j.vaccine.2010.12.125_bib0125","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1056\/NEJMoa0907413","article-title":"Response to a monovalent 2009 influenza A (H1N1) vaccine","volume":"361","author":"Greenberg","year":"2009","journal-title":"N Engl J Med"},{"issue":"25","key":"10.1016\/j.vaccine.2010.12.125_bib0130","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1056\/NEJMoa0907650","article-title":"Trial of 2009 influenza A (H1N1) monovalent MF59-adjuvanted vaccine","volume":"361","author":"Clark","year":"2009","journal-title":"N Engl J Med"},{"issue":"25","key":"10.1016\/j.vaccine.2010.12.125_bib0135","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1056\/NEJMoa0908535","article-title":"A novel influenza A (H1N1) vaccine in various age groups","volume":"361","author":"Zhu","year":"2009","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.vaccine.2010.12.125_bib0140","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1056\/NEJMc0909988","article-title":"Responses to 2009 H1N1 vaccine in children 3 to 17 years of age","volume":"362","author":"Arguedas","year":"2010","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.vaccine.2010.12.125_bib0155","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1016\/j.vaccine.2010.12.128","article-title":"Longevity of the protective immune response induced after vaccination with one or two doses of AS03A-adjuvanted split H5N1 vaccine in ferrets","volume":"29","author":"Baras","year":"2011","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2010.12.125_bib0150","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.vaccine.2009.10.017","article-title":"Priming with AS03A-adjuvanted H5N1 influenza vaccine improves the kinetics, magnitude and durability of the immune response after a heterologous booster vaccination: an open non-randomised extension of a double-blind randomised primary study","volume":"28","author":"Leroux-Roels","year":"2010","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11000065?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11000065?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,7]],"date-time":"2019-06-07T18:05:30Z","timestamp":1559930730000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X11000065"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":30,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["S0264410X11000065"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2010.12.125","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,3]]}}}